- Framework of problems / Rigourous
- Cochrane reviews more rigorous/higher quality than non-Cochrane reviews
- Analysis of Systematic Reviews in Clinical Practice Guidelines for Head and Neck Cancer
Ref ID | 864 |
First Author | J. Dhillon |
Journal | LARYNGOSCOPE |
Year Of Publishing | 2022 |
URL | https://onlinelibrary.wiley.com/doi/10.1002/lary.30051 |
Keywords |
Publication bias Oncology Disclosure Low reporting quality |
Problem(s) |
Funding or sponsor of systematic review not reported Low reporting (PRISMA) quality Low methodological (AMSTAR) quality Poor consideration of publication bias Cochrane reviews more rigorous/higher quality than non-Cochrane reviews |
Number of systematic reviews included | 142 |
Summary of Findings | From 142 systematic reviews underpinning clinical practice guidelines of management of head and neck cancer published between January 2017 and May 2021. A total of 16 Clinical Practive Guidlines (CPGs) and 142 unique Systematic Reviews were included. PRISMA completion ranged from 67.15% to 87.65% across CPGs with a mean of 76.41% (SD = 16.9). AMSTAR-2 completion ranged from 34.38% to 84.38% across CPGs with a mean of 67.55% (SD = 20.9) among all SRs. The lowest rated items included funding sources and publication bias. A higher score was achieved in Cochrane Systematic Reviews but they only accounted for 2.11% (3/142) of all Systematic Reviews. |
Did the article find that the problem(s) led to qualitative changes in interpretation of the results? | Not Applicable |
Are the methods of the article described in enough detail to replicate the study? | No |